These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24755557)

  • 1. Therapeutic implications of microRNAs in pulmonary arterial hypertension.
    Lee A; McLean D; Choi J; Kang H; Chang W; Kim J
    BMB Rep; 2014 Jun; 47(6):311-7. PubMed ID: 24755557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs in PAH: biomarker, therapeutic target or both?
    Meloche J; Pflieger A; Vaillancourt M; Graydon C; Provencher S; Bonnet S
    Drug Discov Today; 2014 Aug; 19(8):1264-9. PubMed ID: 24881781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical effects of epigenetic regulation in pulmonary arterial hypertension.
    Chen D; Gao W; Wang S; Ni B; Gao Y
    Cell Mol Life Sci; 2017 Oct; 74(20):3789-3808. PubMed ID: 28573430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMP type II receptor as a therapeutic target in pulmonary arterial hypertension.
    Orriols M; Gomez-Puerto MC; Ten Dijke P
    Cell Mol Life Sci; 2017 Aug; 74(16):2979-2995. PubMed ID: 28447104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in pulmonary arterial hypertension.
    Zhou G; Chen T; Raj JU
    Am J Respir Cell Mol Biol; 2015 Feb; 52(2):139-51. PubMed ID: 25192340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension.
    Paulin R; Courboulin A; Barrier M; Bonnet S
    J Mol Med (Berl); 2011 Nov; 89(11):1089-101. PubMed ID: 21761156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
    Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
    J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentially expressed plasma microRNAs and the potential regulatory function of Let-7b in chronic thromboembolic pulmonary hypertension.
    Guo L; Yang Y; Liu J; Wang L; Li J; Wang Y; Liu Y; Gu S; Gan H; Cai J; Yuan JX; Wang J; Wang C
    PLoS One; 2014; 9(6):e101055. PubMed ID: 24978044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
    Courboulin A; Ranchoux B; Cohen-Kaminsky S; Perros F; Bonnet S
    Curr Opin Oncol; 2016 Jan; 28(1):72-82. PubMed ID: 26569423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment.
    Bienertova-Vasku J; Novak J; Vasku A
    J Am Soc Hypertens; 2015 Mar; 9(3):221-34. PubMed ID: 25660363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-205-5p suppresses pulmonary vascular smooth muscle cell proliferation by targeting MICAL2-mediated Erk1/2 signaling.
    Tao W; Sun W; Zhu H; Zhang J
    Microvasc Res; 2019 Jul; 124():43-50. PubMed ID: 30853343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in pulmonary arterial remodeling.
    Grant JS; White K; MacLean MR; Baker AH
    Cell Mol Life Sci; 2013 Dec; 70(23):4479-94. PubMed ID: 23739951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary arterial hypertension and microRNAs--an ever-growing partnership.
    Wang Y; Xue XY; Liu YX; Wang KF; Zang XF; Wang J; Wang PL; Zhang J; Pan L; Zhang SY; Wang JX
    Arch Med Res; 2013 Oct; 44(7):483-7. PubMed ID: 24051036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.
    Liu HM; Jia Y; Zhang YX; Yan J; Liao N; Li XH; Tang Y
    Acta Pharmacol Sin; 2019 Apr; 40(4):477-485. PubMed ID: 30038339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA-34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA.
    Wang P; Xu J; Hou Z; Wang F; Song Y; Wang J; Zhu H; Jin H
    Cell Prolif; 2016 Aug; 49(4):484-93. PubMed ID: 27302634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of miRNAs in Pulmonary Hypertension.
    Gupta S; Li L
    Int J Hypertens; 2015; 2015():169069. PubMed ID: 25861465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and their regulators: Potential therapeutic targets in pulmonary arterial hypertension.
    He YZ; Wang YX; Ma JS; Li RN; Wang J; Lian TY; Zhou YP; Yang HP; Sun K; Jing ZC
    Vascul Pharmacol; 2023 Dec; 153():107216. PubMed ID: 37699495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.